TPSTTempest Therapeutics, Inc.
- Market cap
- $8.63M
- as of 2026-10-23
- Latest close
- $0.51
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-13
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Smith Nancy Freda | Sep 22 | Oct 2 | A · derivative | 25,000 | $1.00 | $25,000 | 25,000 | No | Form 4 |
| Angel MatthewCEO and President | Mar 24 | Jun 23 | P | 231,482 | $2.16 | Purchase +$500,001 | 231,482 | No | Form 4 |
| Angel MatthewCEO and President | Mar 24 | Jun 23 | P · derivative | 231,482 | $2.16 | Purchase +$500,001 | 231,482 | No | Form 4 |
| Angel MatthewCEO and President | Mar 24 | Jun 23 | P · derivative | 231,482 | $2.16 | Purchase +$500,001 | 231,482 | No | Form 4 |
| Yee John D. | Jun 4 | Jun 17 | A · derivative | 25,000 | $1.27 | $31,750 | 25,000 | No | Form 4 |
| Richey William Drake | Jun 4 | Jun 8 | A · derivative | 25,000 | $1.27 | $31,750 | 25,000 | No | Form 4 |
| Maestas NicholasChief Financial Officer | Mar 31 | Apr 2 | A · derivative | 140,000 | $1.64 | $229,600 | 140,000 | No | Form 4 |
| Trojanowski JustinCorporate Controller | Mar 31 | Apr 2 | A · derivative | 22,000 | $1.64 | $36,080 | 22,000 | No | Form 4 |
| Angel MatthewCEO and President | Mar 24 | Mar 25 | P | 231,482 | $2.16 | Purchase +$500,001 | 231,482 | No | Form 4 |
| Angel MatthewCEO and President | Feb 4 | Feb 6 | A · derivative | 269,621 | $2.38 | $641,698 | 269,621 | No | Form 4 |
| Pellizzari Christine A | Jan 27 | Jan 28 | A · derivative | 1,230 | $2.94 | $3,616 | 1,230 | No | Form 4 |
| Nichol Geoffrey | Jan 27 | Jan 28 | A · derivative | 1,230 | $2.94 | $3,616 | 1,230 | No | Form 4 |
| Raab Michael | Jan 27 | Jan 28 | A · derivative | 1,230 | $2.94 | $3,616 | 1,230 | No | Form 4 |
| Simantov Ronit | Jan 27 | Jan 28 | A · derivative | 1,230 | $2.94 | $3,616 | 1,230 | No | Form 4 |
| Maestas NicholasChief Financial Officer | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 200,000 | $0.86 | $172,000 | 200,000 | No | Form 4 |
| Whiting SamuelChief Medical Officer | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 270,000 | $0.86 | $232,200 | 270,000 | No | Form 4 |
| Brady Stephen RPresident and CEO | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 550,000 | $0.86 | $473,000 | 550,000 | No | Form 4 |
| Trojanowski JustinCorporate Controller | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 30,000 | $0.86 | $25,800 | 30,000 | No | Form 4 |
| Versant Venture Capital VI, L.P. | Aug 12, 2024 | Aug 12, 2024 | S | 387,999 | $1.10 | Sale −$426,799 | 209,941 | No | Form 4 |
| Versant Venture Capital VI, L.P. | Aug 8, 2024 | Aug 12, 2024 | S | 400,000 | $1.35 | Sale −$540,000 | 597,940 | No | Form 4 |
| Brady Stephen RPresident and CEO | Jul 3, 2024 | Jul 8, 2024 | P | 35,000 | $2.11 | Purchase +$73,850 | 46,376 | No | Form 4 |
| Whiting SamuelChief Medical Officer | Jul 2, 2024 | Jul 3, 2024 | P | 4,672 | $2.13 | Purchase +$9,951 | 9,573 | No | Form 4 |
| Trojanowski JustinCorporate Controller | Jun 28, 2024 | Jul 2, 2024 | P | 7,500 | $2.16 | Purchase +$16,200 | 22,168 | No | Form 4 |
| Raab Michael | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $3.03 | $48,480 | 16,000 | No | Form 4 |
| Simantov Ronit | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $3.03 | $48,480 | 16,000 | No | Form 4 |
| Nichol Geoffrey | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $3.03 | $48,480 | 16,000 | No | Form 4 |
| Pellizzari Christine A | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $3.03 | $48,480 | 16,000 | No | Form 4 |
| Maestas NicholasVP of Strategy and Finance | Jan 3, 2024 | Jan 5, 2024 | A · derivative | 40,000 | $4.66 | $186,400 | 40,000 | No | Form 4 |
| Trojanowski JustinPrincipal Accounting Officer | Jan 3, 2024 | Jan 5, 2024 | A · derivative | 26,500 | $4.66 | $123,490 | 26,500 | No | Form 4 |
| Whiting SamuelChief Medical Officer | Jan 3, 2024 | Jan 5, 2024 | A · derivative | 100,000 | $4.66 | $466,000 | 100,000 | No | Form 4 |
| Brady Stephen RPresident and CEO | Jan 3, 2024 | Jan 5, 2024 | A · derivative | 250,000 | $4.66 | $1,165,000 | 250,000 | No | Form 4 |
| Maestas NicholasVP of Strategy and Finance | Oct 11, 2023 | Oct 13, 2023 | A · derivative | 100,000 | $9.77 | $977,000 | 100,000 | No | Form 4 |
| Whiting SamuelChief Medical Officer | Oct 11, 2023 | Oct 13, 2023 | A · derivative | 325,000 | $9.77 | $3,175,250 | 325,000 | No | Form 4 |
| Trojanowski JustinCorporate Controller | Oct 11, 2023 | Oct 13, 2023 | A · derivative | 55,000 | $9.77 | $537,350 | 55,000 | No | Form 4 |
| Brady Stephen RPresident and CEO | Oct 11, 2023 | Oct 13, 2023 | A · derivative | 725,000 | $9.77 | $7,083,250 | 725,000 | No | Form 4 |